摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(吡啶-2-羰基)苯甲酸 | 27693-49-8

中文名称
2-(吡啶-2-羰基)苯甲酸
中文别名
——
英文名称
2-(2-pyridylcarbonyl)benzoic acid
英文别名
2-(pyridine-2-carbonyl)-benzoic acid;2-(Pyridine-2-carbonyl)benzoic acid
2-(吡啶-2-羰基)苯甲酸化学式
CAS
27693-49-8
化学式
C13H9NO3
mdl
——
分子量
227.219
InChiKey
WTUKXPYMQWVXOB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    67.3
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933399090

SDS

SDS:3ea9b40404c12e07f3e00b64031a5c42
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(吡啶-2-羰基)苯甲酸potassium carbonate一水合肼 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 10.0h, 生成 2-(2-Imidazol-1-ylethyl)-4-pyridin-2-ylphthalazin-1-one
    参考文献:
    名称:
    Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 1. 2-[2-(1-Imidazolyl)alkyl]-1(2H)-phthalazinones
    摘要:
    A number of 4-substituted 2-[omega-(1-imidazolyl)allryl]-1(2H)-phthalazinones were synthesized in order to develop agents possessing both thromboxane Az synthetase inhibitory and bronchodilatory activities. The pharmacological evaluation of these compounds disclosed that they have both activities to various extents. Both activities were slightly dependent on the length of the 2-substituents and largely affected by the nature of the 4-substituents. Compounds bearing phenyl and thienyl groups exhibited relatively high and well-rounded activities. Among these compounds, 12j and 15f were found to be the most effective agents having well-rounded activities in vitro and in vivo. Introduction of a carboxyl group reduced both activities contrary to our expectation. 4-(3-Pyridyl)phthalazinone 18b was of particular interest because of unexpectedly high in vivo activities in spite of an absence of significant in vitro activities.
    DOI:
    10.1021/jm00077a008
  • 作为产物:
    描述:
    2-吡啶甲酸苯酐硝基苯 为溶剂, 反应 4.0h, 以38%的产率得到2-(吡啶-2-羰基)苯甲酸
    参考文献:
    名称:
    Karlivan, G. A.; Valter, R. E., Journal of Organic Chemistry USSR (English Translation), 1984, vol. 20, p. 605 - 606
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Metallation of pyridines and quinolines in the presence of a remote carboxylate group. New syntheses of heterocyclic quinones
    作者:Anne-Sophie Rebstock、Florence Mongin、François Trécourt、Guy Quéguiner
    DOI:10.1039/b312723k
    日期:——
    2-(3- and 2-Pyridylcarbonyl)benzoic acids (2, 3), 2-(2-pyridylcarbonyl)thiophene-3-carboxylic acid (6), 2-(3-quinolylcarbonyl)benzoic acid (10), and most of the corresponding esters (compounds 1, 7 and 9) are readily synthesized and involved in a deprotonation–condensation sequence. Biologically active aza-anthraquinones such as benzo[g]isoquinoline-5,10-dione (2-azaanthraquinone, 4) and benzo[g]quinoline-5,10-dione (1-azaanthraquinone, 5) are prepared using the strategy. Extension to other heterocyclic quinones such as thieno[3,2-g]quinoline-4,9-dione (8) and benzo[j]phenanthridine-7,12-dione (11) is also investigated.
    2-(3-和2-吡啶羧基)苯甲酸(2,3)、2-(2-吡啶羧基)噻吩-3-羧酸(6)、2-(3-喹啉羧基)苯甲酸(10)及大多数对应的酯(化合物1、7和9)可以方便地合成,并涉及去质子化-缩合的反应序列。生物活性的氮杂蒽醌如苯并[g]异喹啉-5,10-二酮(2-氮杂蒽醌,4)和苯并[g]喹啉-5,10-二酮(1-氮杂蒽醌,5)也是采用该策略制备的。此外,还研究了扩展至其他杂环醌的可能性,如噻吩[3,2-g]喹啉-4,9-二酮(8)和苯并[j]苯anthridine-7,12-二酮(11)。
  • Selective non-nucleoside HIV-1 reverse transcriptase inhibitors. New 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity
    作者:Alfred Mertens、Harald Zilch、Bernhard Koenig、Wolfgang Schaefer、Thomas Poll、Wolfgang Kampe、Hans Seidel、Ulrike Leser、Herbert Leinert
    DOI:10.1021/jm00069a011
    日期:1993.8
    A series of substituted 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds 1-73 were synthesized and evaluated for their ability to inhibit reverse transcriptase (RT) of the human immune deficiency virus 1 (HIV-1) and replication of HIV-1 in MT2 cells. The antiviral activity of these compounds depends on the stereoselective configuration of the substituent in position 9b. Structure-activity
    合成了一系列取代的2,3-二氢噻唑并[2,3-a] isoindol-5(9bH)-ones和相关化合物1-73,并评估了其抑制人免疫缺陷病毒逆转录酶(RT)的能力。 1(HIV-1)和HIV-1在MT2细胞中的复制。这些化合物的抗病毒活性取决于位置9b上取代基的立体选择性构型。在这一系列化合物中进行了结构活性研究,以确定抗病毒活性的最佳取代基。发现最有效的抑制剂是2,3-二氢噻唑并[2,3-a] isoindol-5(9bH)-一类化合物,该化合物在9b位带有苯环系统,可选地被一个或两个甲基或氯原子取代最活跃的类似物(R)-(+)-1,(R)-(+)-6,(R)-(+)-13,(R)-(+)-26,
  • Isoindol-1-one Analogues of 4-(2‘-methoxyphenyl)-1-[2‘-[<i>N</i>-(2‘‘-pyridyl)-<i>p</i>-iodobenzamido]ethyl]piperazine (<i>p</i>-MPPI) as 5-HT<sub>1A</sub> Receptor Ligands
    作者:Zhi-Ping Zhuang、Mei-Ping Kung、Mu、Hank F. Kung
    DOI:10.1021/jm970296s
    日期:1998.1.1
    moderate to low brain uptakes with little or no specific localization in hippocampal region, where 5-HT1A receptors are concentrated. These data indicate that the new iodinated ligands showed high binding affinities and better metabolic stability but displayed unexpectedly low selective binding to 5-HT1A receptors in vivo. Additional structural modifications may be needed to correct the unfavorable properties
    尤其是2- 2- [4-(2-(2-甲氧基苯基)哌嗪-1-基]乙基} -6-硝基-3-苯基-2,3-二氢异吲哚-1-酮,15,3-羟基-6-碘-2- 2- [4-(2-(2-甲氧基苯基)哌嗪-1-基]乙基}-3-苯基-2,3-二氢异吲哚-1-酮18和6-碘-2- 2- [ 4-(2-甲氧基苯基)哌嗪-1-基]乙基} -3-苯基-2,3-二氢异吲哚-1-酮21,其Ki值分别为0.05、0.65和0.07 nM。其他环化酰胺衍生物5-(4-溴苯基)-1- 2- [4-(2-(2-甲氧基苯基)-哌嗪-1-基]乙基}吡咯烷酮-2-one的5-HT1A受体的亲和力25 ,5-(4-碘苯基)-1- 2- [4-(2-甲氧基苯基)哌嗪-1-基]乙基}吡咯烷酮-2-酮27和2- 2- [4-(2-甲氧基苯基)哌嗪-1-基]乙基} -2,3-二氢-异吲哚-1-酮29分别为1.09、2.54和14
  • Bioinspired Copper(I) Complexes that Exhibit Monooxygenase and Catechol Dioxygenase Activity
    作者:Aline Arnold、Ramona Metzinger、Christian Limberg
    DOI:10.1002/chem.201405155
    日期:2015.1.12
    New tripodal ligand L2 featuring three different pyridyl/imidazolyl‐based N‐donor units at a bridgehead C atom, from which one of the imidazolyl units is separated by a phenylene linker, was synthesized and investigated with regards to copper(I) complexation. The resulting complex [(L2)Cu]OTf (2OTf), the known complex [(L1)Cu]OTf (1OTf; L1 differs from L2 in that it lacks the phenylene spacer) and
    合成并研究了新的三脚架配体L2,该配体在桥头C原子上具有三个不同的基于吡啶基/咪唑基的N供体单元,其中一个咪唑基单元被亚苯基连接基隔开,并就铜(I)络合进行了研究。生成的络合物[(L2)Cu] OTf(2 OTf),已知络合物[(L1)Cu] OTf(1 OTf;L1与L2的不同之处在于它缺少亚苯基间隔基)和[(L3)Cu] OTf(3 OTf)是由已知的具有吡啶基,吡唑基和咪唑基供体的手性,三脚架,N供体配体制备的,经测试用作O 2氧化2,4-二叔丁基苯酚钠(NaDTBP)的催化剂。确实,他们介导了NaDTBP的氧化作用,主要产生了相应的儿茶酚酸和醌(Q)。配合物1 OTf,2 OTf和3 OTf均不优于其他配合物,因为产率相当,并且如果同时添加苯酚DTBP可以保证质子的存在氧化也可以催化进行。对于所有配合物,在一定条件下(浓溶液,高NaDTBP含量),化学计量氧化也被发现也产生典型的产物,该产物通常被金属介导的邻苯二酚与O
  • Macrolide antibiotics
    申请人:Alihodzic Sulejman
    公开号:US20050215495A1
    公开(公告)日:2005-09-29
    The present invention relates to 11,12 γ lactone ketolides of formula (I) wherein R, R 1 , R 2 , R 3 are as defined herein and pharmaceutically acceptable salts and solvates thereof, to process for their preparation and their use in therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body.
    本发明涉及式(I)的11,12γ内酯酮类药物,其中R,R1,R2,R3如本文所定义,并且其药学上可接受的盐和溶剂合物,以及其制备过程和在人体或动物体内治疗或预防系统性或局部细菌感染中的用途。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台